STAT Virtual Event: The State of Biosimilars: What to Watch
Join STAT for a discussion of what’s next for biosimilars, and what key signals will indicate how they might be prescribed, or paid for.
Join STAT for a discussion of what’s next for biosimilars, and what key signals will indicate how they might be prescribed, or paid for.
Genetic evidence of H5N1 bird flu virus has been found in grocery store milk, according to the FDA. In this video, STAT explains what is…
Biogen on Wednesday reported first-quarter earnings that beat Wall Street expectations largely on reduced expenses.
As the Covid-19 experience showed, trying to address IP during a pandemic doesn’t work, and voluntary sharing of IP during a pandemic doesn’t work.
The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.
Costs for the U.S. health care system and the federal government will climb thanks to weight loss drugs, two new reports show.
It takes great minds with a lot of heart to find a cure for diseases like Duchenne muscular dystrophy.
The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive amounts of vaccine.
The agency simply doesn’t have enough resources to challenge but 1% of hospital mergers, so they continue to result in less competition and higher prices.
Novo Nordisk’s move to discontinue its Levemir insulin has left patients to “pick up the pieces.”
The FTC’s noncompete ban could force sweeping changes in the health care industry, but implementation of the rule will almost certainly be held up by…